Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
Risk & Insurance: How Case Managers Can Assist Employees Who Are Delaying Care Due to COVID-Related Anxieties
Injured workers may try to delay treatment over fears that they will contract COVID-19.
Enlyte
Conference
AASP Northeast Trade Show
Visit Us at the Exhibit Booth Northeast is an eve
Workers' Comp
White Paper
Substance Misuse Recovery Network
For all the progress our nation has made in reducing opioid prescriptions, misuse of these powerful analgesics remains an intractable problem.
Mitchell
News Release
In a Hazy Election, Marijuana Is a Clear Winner
Voters in several states approved ballot measures to expand legalization of marijuana.
Mitchell
News Release
Evzio Naloxone Auto-Injectors Discontinued
Learn how this could affect the workers' compensation and auto casualty industries.
Workers' Comp
News Release
Business Insurance: Lack of guidelines complicates COVID-19 care
Evidence-based medicine is a mainstay in the workers compensation industry, and those aiming to treat workers with COVID-19 are relying on an